- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Iodine-131 trips off false alarms in patient travel
Radiologists should not only take their patients' history but perhaps also record their future travel plans. Apparently, individuals undergoing diagnostic or therapeutic nuclear medicine procedures can trip radiation detectors designed to catch terrorists smuggling radioactive material.
Radiologists should not only take their patients' history but perhaps also record their future travel plans. Apparently, individuals undergoing diagnostic or therapeutic nuclear medicine procedures can trip radiation detectors designed to catch terrorists smuggling radioactive material.
One man set off an alarm in a tunnel while riding a bus from New York to Atlantic City, NJ, a few years ago. In the 1980s, two people undergoing radionuclide therapy set off detectors in the White House.
But the potential for these false alarms is rising as portable radiation monitors proliferate and the number of nuclear medicine scans increases, Dr. Lionel Zuckier said at the 2004 RSNA meeting.
Zuckier and colleagues at the University of Medicine and Dentistry of New Jersey found that iodine-131 can trigger alarms up to three months after its administration; gallium-67 and thallium-201 up to 30 days; indium-111 up to 17 days; and technetium-99m and iodine-123 up to three days.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
